Efferent Labs’ Living Biosensor Could Save Pharma, Device Firms Money

Related Posts

Third Trademark Issued

(BUFFALO, NY) Apr. 1, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in

About Us

Efferent Labs offers a live, cellular data acquisition platform that will radically alter the landscape of pre-clinical research in animals.

 

Let’s Socialize

Popular Post